Candriam S.C.A. lowered its position in Docusign Inc. (NASDAQ:DOCU – Free Report) by 20.1% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 67,243 shares of the company’s stock after selling 16,873 shares during the period. Candriam S.C.A.’s holdings in Docusign were worth $4,848,000 as of its most recent SEC filing.
Several other hedge funds have also added to or reduced their stakes in DOCU. Centaurus Financial Inc. grew its stake in Docusign by 2.6% in the second quarter. Centaurus Financial Inc. now owns 5,398 shares of the company’s stock valued at $420,000 after acquiring an additional 136 shares during the period. Mitchell & Pahl Private Wealth LLC lifted its holdings in shares of Docusign by 0.7% during the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 21,422 shares of the company’s stock valued at $1,544,000 after purchasing an additional 149 shares in the last quarter. Moors & Cabot Inc. grew its position in shares of Docusign by 5.7% in the 2nd quarter. Moors & Cabot Inc. now owns 2,780 shares of the company’s stock valued at $217,000 after purchasing an additional 150 shares during the period. Savvy Advisors Inc. increased its stake in Docusign by 5.4% during the 2nd quarter. Savvy Advisors Inc. now owns 3,090 shares of the company’s stock worth $241,000 after purchasing an additional 157 shares in the last quarter. Finally, iA Global Asset Management Inc. increased its stake in Docusign by 2.1% during the 2nd quarter. iA Global Asset Management Inc. now owns 7,872 shares of the company’s stock worth $613,000 after purchasing an additional 160 shares in the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.
Analysts Set New Price Targets
Several research firms have recently weighed in on DOCU. Piper Sandler reduced their price target on shares of Docusign from $90.00 to $75.00 and set a “neutral” rating for the company in a report on Friday, December 5th. Wells Fargo & Company cut their price objective on shares of Docusign from $85.00 to $75.00 and set an “equal weight” rating on the stock in a research report on Friday, December 5th. Cantor Fitzgerald reaffirmed an “outperform” rating on shares of Docusign in a research note on Wednesday, December 17th. Wedbush dropped their price target on Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a research note on Friday, December 5th. Finally, Bank of America cut their price target on Docusign from $102.00 to $82.00 and set a “neutral” rating on the stock in a report on Friday, December 5th. Six equities research analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $85.13.
Docusign Stock Performance
Shares of NASDAQ DOCU opened at $44.34 on Thursday. The stock has a 50 day moving average price of $61.97 and a 200 day moving average price of $69.12. Docusign Inc. has a 52 week low of $44.05 and a 52 week high of $94.67. The stock has a market capitalization of $8.88 billion, a PE ratio of 31.01, a price-to-earnings-growth ratio of 2.08 and a beta of 1.00.
Key Stories Impacting Docusign
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: Management is pursuing initiatives to streamline contract workflows, which could improve margins and accelerate product adoption over time — a constructive operational development for long-term revenue and profitability prospects. DocuSign eyes streamlining contracts
- Neutral Sentiment: Several comparison/analysis pieces have been published weighing DocuSign versus peers (Bitdeer, Zeta Global) — useful context for relative valuation but not immediate corporate moves. Which Is a Better Investment, Bitdeer Technologies Group or DocuSign, Inc. Stock? Which Is a Better Investment, DocuSign, Inc. or Zeta Global
- Neutral Sentiment: Standard quote and market pages reflecting today’s price action and stats are available for traders tracking intraday moves. DocuSign quote on Yahoo Finance
- Negative Sentiment: DocuSign has hit a 52-week low, a clear negative technical signal that can trigger additional selling and weaken investor sentiment. Docusign stock hits 52-week low
- Negative Sentiment: Short interest rose materially through late January: as of Jan. 30 there were ~8.87M shares short (up ~46.6% vs mid-January), about 4.5% of the float and a short-interest ratio near 2.1 days — elevated shorting can amplify downside pressure during weak trading. (Internal short-interest data reported 2/10–2/11.)
- Negative Sentiment: Coverage pieces note that DocuSign is underperforming the broader market and that shares have been in a year-long decline, reinforcing negative momentum and cautious market positioning. DocuSign dips more than broader market
Insiders Place Their Bets
In other Docusign news, CRO Paula Hansen sold 6,000 shares of the business’s stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $67.05, for a total transaction of $402,300.00. Following the completion of the transaction, the executive owned 68,970 shares of the company’s stock, valued at approximately $4,624,438.50. The trade was a 8.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Blake Jeffrey Grayson sold 9,515 shares of the business’s stock in a transaction on Wednesday, December 17th. The stock was sold at an average price of $68.33, for a total transaction of $650,159.95. Following the sale, the chief financial officer directly owned 118,213 shares in the company, valued at approximately $8,077,494.29. The trade was a 7.45% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 78,292 shares of company stock valued at $5,374,260 over the last three months. 1.01% of the stock is owned by corporate insiders.
About Docusign
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Featured Stories
- Five stocks we like better than Docusign
- Trump’s Hand-Written Letter Will Shock his Haters
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
